Medical News

RSS

Emergency mental health admission costs for youth nearly quadruple over a decade

The total cost of emergency admissions for mental health among children and young people in England rose from £22.5 million in 2012/13 to £87.3 million in 2021/22, finds research published online in the journal BMJ Open.

20 May 2026

Rerouting dead tumor debris enhances cancer immunotherapy outcomes

As tumors outgrow their blood and nutrient supplies, or respond to treatments like chemotherapy and radiotherapy, individual cancer cells die, exposing their internal scaffolds.

20 May 2026

Plant-based eye drops harness photosynthesis to heal dry eyes

What if your eyes could use light to heal themselves? Drawing inspiration from how plants harness sunlight, researchers at the National University of Singapore (NUS) are pioneering a revolutionary treatment for dry eye disease.

20 May 2026

Engineered nanomaterials optimize delivery barriers in cancer immunotherapy

Cancer immunotherapy works by mobilizing the body's own immune system to recognize and destroy malignant cells.

20 May 2026

Spatial modeling of tissue compartments predicts breast cancer treatment response

HER2-positive breast cancer accounts for about 20% of breast cancer cases and is generally associated with more aggressive behavior and a higher risk of distant metastasis, while pathologic complete response (pCR) after neoadjuvant chemotherapy is strongly linked to better survival outcomes.

20 May 2026

Sino Biological launches XPressMAX™ Cell-Free Protein Synthesis Kit, accelerating AI-powered high-throughput antibody drug discovery

Sino Biological, Inc., a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02) , a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery.

From Sino Biological Inc. 20 May 2026

Blood protein biomarkers predict psychosis risk in Asian youth

A new study by researchers from NHG Health's Institute of Mental Health (IMH) and Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine) has identified blood-based proteomic biomarkers that may help predict who among the at-risk group is at increased risk of developing psychosis.

20 May 2026

Diverse AI foundation models transform universal eye care imaging

Artificial intelligence (AI) has already changed many aspects of medical imaging, but traditional ophthalmic AI systems are often built for a single disease, dataset, or task.

20 May 2026

Aerobic exercise mitigates nanoplastic damage in female zebrafish

Using female zebrafish as a model, researchers have found that aerobic exercise may influence various connections in the body to lessen the damaging health impacts of environmental nanoplastics.

20 May 2026

Early electronic advance directives reduce burdensome end-of-life care

Advance directives document patient preferences for future care, including end-of-life. An analysis in the Journal of the American Geriatrics Society found that older patients with an advance directive that had been uploaded into the electronic health record at least six months before death were 25% less likely to experience potentially burdensome end-of-life care (19.9% versus 26.8%) and 31% less likely to have died in the hospital (23.2% versus 32.1%).

20 May 2026

Vitamin C may reduce cancer-linked digestive chemical reactions

A new study from the University of Waterloo uses mathematical modeling to examine how Vitamin C affects chemical reactions in the digestive system that are linked to cancer development.

20 May 2026

Bedfont® Scientific targets international growth at EAACI Congress 2026

Bedfont® Scientific Ltd., an innovative leader in the medical breath analysis industry with almost 50 years of experience, is pleased to join thousands of healthcare experts at this year’s European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026 at stand I03 to showcase its NObreath® and Gastrolyzer® range of non-invasive breath analysis devices.

From NObreath 20 May 2026

Researchers uncover new genetic links influencing blood lipid composition

DZNE researchers have generated new insights into how the human genome shapes the chemical composition and concentration of blood lipids.

20 May 2026

Severe asthma patients often face multiple overlooked health conditions

Most people living with severe asthma are also battling other health conditions that go under the radar, a major new study has found.

20 May 2026

Digital pens and tablets could offer non-invasive tools for routine dementia screening

Handwriting requires a combination of fine motor control and a complex set of mental skills, such as selecting, organizing, and interpreting sensory information, making it a cognitively challenging task. Because of its high demand on the brain, it is a potential marker of cognitive decline, especially as we age. Then, our handwriting often becomes slower or choppier.

20 May 2026

How food and alcohol cues leave different signatures in the brain

Food and alcohol cues appear to engage partially distinct EEG oscillatory patterns, with food cues linked mainly to increased delta activity and alcohol-related processing showing alpha and delta differences in key contrasts. The effects were strongest in participants with relatively higher AUDIT scores, but neural changes were small and subjective cue responses were more robust.

20 May 2026

Scientists uncover why genome guardian p53 protein is uniquely prone to collapse

The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it is also one of the most frequently mutated and dysfunctional proteins in human tumors.

20 May 2026

Women may face greater cognitive impact from dementia risk factors

Researchers from the University of California San Diego School of Medicine found that women not only experience a higher burden of certain modifiable dementia risk factors, but also appear more vulnerable to their effects on cognitive function.

20 May 2026

Study reveals cellular mechanisms driving resistance to targeted cancer therapies

Despite impressive innovations in medicine, most advanced-stage cancers still carry a grim prognosis. Developing more effective treatments requires a deeper understanding of the cellular processes that drive the formation and growth of common cancers.

20 May 2026

Ensitrelvir cuts household COVID-19 risk when given after exposure

Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household contacts when given within 72 hours after symptom onset in the infected index patient. In the phase 3 SCORPIO-PEP trial, COVID-19 occurred in 2.9% of ensitrelvir recipients versus 9.0% of placebo recipients, with similar overall adverse-event rates.

20 May 2026